Literature DB >> 1926655

Growth fraction of human bladder tumors.

H Tsujihashi1, A Nakanishi, H Matsuda, S Uejima, T Kurita.   

Abstract

The growth fraction of bladder tumors was immunohistochemically assessed in situ using anti-DNA polymerase (Pol alpha) monoclonal antibody. This enzyme is known to be present in the nucleus of the cells in G1, S, and G2 phases. The percentage of labeled cells was expressed as the labeling index (LI). The average LI was 6.0% in normal epithelium and 17.8% in bladder tumors, this difference being significant. The labeled cells were distributed throughout both the basal and surface layers of bladder tumors. However, in some bladder tumors, the distribution of Pol alpha-labeled cells varied from area to area. The higher fraction of labeled cells was found in high grade or invasive tumors. Papillary and nodular bladder tumors showed a greater rate of cell proliferation than papillary tumors. These findings suggest that Pol alpha immunostaining could be a potent tool for easy and quick evaluation of proliferating cells in bladder tumors, thereby providing a supplement to conventional histological findings.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926655     DOI: 10.1007/bf00305297

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  Histology and cell proliferation in human bladder tumors. An autoradiographic study.

Authors:  B Hainau; P Dombernowsky
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase alpha.

Authors:  M Mushika; T Miwa; Y Suzuoki; K Hayashi; S Masaki; T Kaneda
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

4.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Intracellular localization and metabolism of DNA polymerase alpha in human cells visualized with monoclonal antibody.

Authors:  H Nakamura; T Morita; S Masaki; S Yoshida
Journal:  Exp Cell Res       Date:  1984-03       Impact factor: 3.905

6.  Production and characterization of monoclonal antibody against 10S DNA polymerase alpha from calf thymus.

Authors:  S Masaki; H Shiku; T Kaneda; O Koiwai; S Yoshida
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

7.  Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.

Authors:  M P Gallee; E Visser-de Jong; F J ten Kate; F H Schroeder; T H Van der Kwast
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

8.  S phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labeling.

Authors:  R Nemoto; K Uchida; K Hattori; T Shimazui; Y Nishijima; S Saito; K Koiso; M Harada
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

9.  Cell proliferation of human bladder tumors.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  J Urol       Date:  1989-10       Impact factor: 7.450

10.  Double immunoenzymatic detection of surface phenotype of proliferating lymphocytes in situ with monoclonal antibodies against DNA polymerase alpha and lymphocyte membrane antigens.

Authors:  R Namikawa; R Ueda; T Suchi; G Itoh; K Ota; T Takahashi
Journal:  Am J Clin Pathol       Date:  1987-06       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.